1 citations
,
September 2017 in “Asian Journal of Pharmaceutical and Clinical Research” This case report documents warfarin-induced alopecia in a 39-year-old male in Southern India, adding to the limited case reports on this potential side effect.
7 citations
,
May 2017 in “Research and Practice in Thrombosis and Haemostasis” This case report observed that a 20-year-old female with recurrent DVTs experienced reversible alopecia with various anticoagulants, except fondaparinux which allowed long-term treatment without this side effect.
322 citations
,
October 2006 in “British Journal of Clinical Pharmacology” This article reviews the history and challenges of warfarin use and suggests that monitoring genetic and environmental factors could improve individualized dosing and safety, but no new results are reported.
July 2002 in “Australasian Journal of Dermatology” This announcement in the Australasian Journal of Dermatology provides no new research findings or study results.
January 2020 in “Jornal Vascular Brasileiro” This review discusses the mechanisms behind alopecia during anticoagulation therapy and current treatments but reports no new clinical results.